Citations

Mayo Clinic

Showing 10 of 108602 citations.

The Goal of Achieving High-Quality Surgical First-Line Therapy in Patients with Penile Cancer Is Important; However, Some Collective Efforts Are Still Required in Order to Reach It. Comment on Brassetti et al. Combined Reporting of Surgical Quality and Can
May, Matthias , Lebentrau, Steffen , Protzel, Chris, Chahoud, Jad , Pettaway, Curtis A. , Pagliaro, Lance C. , Watkin, Nick , Spiess, Philippe E. , Spiess, Philippe E , Ayres, Benjamin Edward , Albersen, Maarten , Brouwer, Oscar R. , Necchi, Andrea , Hakenberg, Oliver Walter

Current Oncology | April 20, 2023 | Volume: 30 | Issue: 4 | Pages: 4269-4274

10.3390/curroncol30040325 | PMID 37185438 Get It

We read with great interest the manuscript by Brassetti et al. recently published in your journal and hope it will encourage discussion and debate around the optimization of the surgical management of patients with penile cancer (PECa) [...]
Survey of Nutrition Education Among Medical Students
Duggan, Michael P. , Kodali, Anahita , Panton, Zach A, Smith, Shannon M. , Riew, Grant J. , Donaghue, Jack F. , Leya, Gregory , Panton, Zachary A , Briggs, Logan

Journal of Wellness | April 20, 2023 | Volume: 4 | Issue: 2 | Pages: No page available

10.55504/2578-9333.1167 Get It

Introduction: The current literature regarding both specific interventions and the current level of nutrition education in the United States is scarce. The purpose of this paper is to provide medical student perspectives on both the degree and necessity of nutrition education during medical school. Methods: Medicine in Motion (MM) is a non-profit student-run organization founded in 2018 that aims to address burnout in medicine through physical activity, community service, and philanthropy. MM issued a survey to nine of its chapters in January 2021 to assess a range of topics including burnout, physical activity, and nutrition education. Results: Of 5500 invited students, 1182 (21.5%) responded. An average of 1.2 hours of formal nutrition education per year was reported across all participants. Students who received any degree of nutritional education reported 2.9 hours per year. Most students (57.6%) had not participated in a medical school course that provided formal education in nutrition. Of those that did participate in a nutrition course (42.4%), the course was required for 84.7% of students and the majority (80.1%) received 0-10 hours of nutrition education. Most respondents (88.7%) reported that requiring formal nutrition education should be a graduation requirement and a similar number of students (89.3%) believe medical students should receive formal training on nutrition counseling for patients. The majority (93.3%) of students either somewhat or strongly agreed that understanding the effects of nutrition/eating decisions on the human body is critical to maximizing patient care. Conclusion: Based on prior studies, physicians feel underprepared to provide nutrition counseling to their patients despite the large role poor diet plays in the burden of disease. Most medical students in this cohort believe that understanding nutrition is vital to maximize patient care. Funding and curricular changes should be allocated towards expanding the nutrition curriculum across U.S. medical schools.
Why is the Implementation of Beta-Lactam Therapeutic Drug Monitoring for the Critically Ill Falling Short? A Multicenter Mixed-Methods Study
Frazee, Erin N. , Chitre, Pooja N., Shepel, Kathryn, Aziz, Mohd. Hafiz Abdul, Ausman, Sara , Moreland-Head, Lindsay N, Jannetto, Paul J. , Mara, Kristin C. , Boehmer, Kasey R. , Shepel, Kathryn K, Ausman, Sara E., Mara, Kristin C , Chitre, Pooja , Pine, Kathleen H. , Rule, Andrew D. , Al‐Shaer, Mohammad H. , Abdul-Aziz, Mohd Hafiz , Roberts, Jason A , Scheetz, Marc H. , Ausman, Sara E , Rivera, Christina G.

Therapeutic Drug Monitoring | April 20, 2023 | Volume: 45 | Issue: 4 | Pages: 508-518

10.1097/ftd.0000000000001059 | PMID 37076424 Get It

Background: Beta-lactam therapeutic drug monitoring (BL TDM; drug level testing) can facilitate improved outcomes in critically ill patients. However, only 10%–20% of hospitals have implemented BL TDM. This study aimed to characterize provider perceptions and key considerations for successfully implementing BL TDM. Methods: This was a sequential mixed-methods study from 2020 to 2021 of diverse stakeholders at 3 academic medical centers with varying degrees of BL TDM implementation (not implemented, partially implemented, and fully implemented). Stakeholders were surveyed, and a proportion of participants completed semistructured interviews. Themes were identified, and findings were contextualized with implementation science frameworks. Results: Most of the 138 survey respondents perceived that BL TDM was relevant to their practice and improved medication effectiveness and safety. Integrated with interview data from 30 individuals, 2 implementation themes were identified: individual internalization and organizational features. Individuals needed to internalize, make sense of, and agree to BL TDM implementation, which was positively influenced by repeated exposure to evidence and expertise. The process of internalization appeared more complex with BL TDM than with other antibiotics (ie, vancomycin). Organizational considerations relevant to BL TDM implementation (eg, infrastructure, personnel) were similar to those identified in other TDM settings. Conclusions: Broad enthusiasm for BL TDM among participants was found. Prior literature suggested that assay availability was the primary barrier to implementation; however, the data revealed many more individual and organizational attributes, which impacted the BL TDM implementation. Internalization should particularly be focused on to improve the adoption of this evidence-based practice.
Artificial Intelligence: Singularity Approaches
TerKonda, Sarvam P. , TerKonda, Anurag A., Sacks, Justin M. , Kinney, Brian M. , Gurtner, Geoff C., Nachbar, James M., Reddy, Sashank , Jeffers, Lynn L., Jeffers, Lynn

Plastic & Reconstructive Surgery | April 19, 2023 | Volume: 153 | Issue: 1 | Pages: 204e-217e

10.1097/prs.0000000000010572 | PMID 37075274 Get It

Summary: Artificial intelligence (AI) has been a disruptive technology within health care, from the development of simple care algorithms to complex deep-learning models. AI has the potential to reduce the burden of administrative tasks, advance clinical decision-making, and improve patient outcomes. Unlocking the full potential of AI requires the analysis of vast quantities of clinical information. Although AI holds tremendous promise, widespread adoption within plastic surgery remains limited. Understanding the basics is essential for plastic surgeons to evaluate the potential uses of AI. This review provides an introduction of AI, including the history of AI, key concepts, applications of AI in plastic surgery, and future implications.
Tris-Hydroxymethyl Aminomethane in Critically Ill Adults: A Systematic Review
Radosevich, Misty A., Wieruszewski, Patrick M. , Wittwer, Erica D. , Wieruszewski, Patrick M

Anesthesia & Analgesia | April 19, 2023 | Volume: 137 | Issue: 5 | Pages: 1007-1018

10.1213/ane.0000000000006485 | PMID 37075790 Get It

Tris-hydroxymethyl aminomethane (THAM) is an amino alcohol used clinically to buffer acid loads and raise pH in acidotic conditions. Unlike sodium bicarbonate, which increases plasma sodium levels with use and produces carbon dioxide (CO 2 ) as part of the buffering process, THAM does neither. Although not widely used in modern critical care and unavailable for clinical use in 2016, THAM has been available in the United States since 2020. Clinical experience and existing literature suggest that THAM may have clinical utility in acid-base management in conditions such as liver transplantation where rising sodium levels during perioperative care may be dangerous, and in managing acid-base derangements during care of patients with acute respiratory distress syndrome (ARDS). To clarify the evidence base supporting the clinical use of THAM, we conducted a systematic review to assess the efficacy and safety of THAM as a buffering agent in critically ill adults using Ovid EBM Reviews, Ovid Embase, Ovid Medline, Scopus, and Web of Science Core Collection. Randomized-, crossover-, retrospective cohort-, parallel-designed clinical trials, case series, and case reports of adult patients who received THAM in the operative or critical care setting were included. Conference abstracts of qualifying study designs were also included. Two independent reviewers extracted the data regarding the study details, demographics, treatment, and outcomes data. A third reviewer adjudicated discrepancies. A total of 21 studies including 3 randomized controlled trials, 5 observational studies, 4 case series, and 9 case reports met inclusion criteria. Eight studies (38%) were abstracts published in conference proceedings. In total, 417 critically ill patients received THAM to treat acidosis in critically ill surgical and nonsurgical patients, during liver transplantation, and in ARDS. In general, THAM corrected acidosis with an efficacy equivalent to sodium bicarbonate and did so with less hypercarbia and hypernatremia. Adverse effects of THAM included hyperkalemia, hypoglycemia, ventilator depression, and tissue damage with extravasation. We conclude that THAM may have potential advantages in some critical care settings, but that clinical evidence is limited, and high-quality evaluations are necessary.
Neuromuscular ultrasound standardized scanning techniques and protocols: Expert panel recommendations
Tawfik, Eman A. , Cartwright, Michael S. , Alfen, Nens van , Axer, Hubertus , Boon, Andrea J. , Grimm, Alexander , Hobson‐Webb, Lisa D., Kerasnoudis, Antonios , Mandeville, Ross , Preston, David C. , Sakamuri, Sarada, Shin, Susan , Shook, Steven J. , Walker, Francis O. , van Alfen, Nens , Crump, Nicholas , Kerasnoudis, Antonios , Preston, David C , Shin, Susan , Crump, Nicholas , Shahrizaila, Nortina , Wilder‐Smith, Einar

Muscle & Nerve | April 19, 2023 | Volume: 68 | Issue: 4 | Pages: 375-379

10.1002/mus.27830 | PMID 37074101 Get It

AbstractNeuromuscular ultrasound has become an integral part of the diagnostic workup of neuromuscular disorders at many centers. Despite its growing utility, uniform standard scanning techniques do not currently exist. Scanning approaches for similar diseases vary in the literature creating heterogeneity in the studies as reported in several meta‐analysis. Moreover, neuromuscular ultrasound experts including the group in this study have different views with regards to technical aspects, scanning protocols, and the parameters that should be assessed. Establishing standardized neuromuscular scanning protocols is essential for the development of the subspeciality to ensure uniform clinical and research practices. Therefore, we aimed to recommend consensus‐based standardized scanning techniques and protocols for common neuromuscular disorders using the Delphi approach. A panel of 17 experts participated in the study, which consisted of three consecutive electronic surveys. The first survey included voting on six scanning protocols addressing the general scanning technique and five common categories of suspected neuromuscular disorders. The subsequent surveys focused on refining the protocols and voting on new steps, rephrased statements, or areas of non‐agreement. A high degree of consensus was achieved on the general neuromuscular ultrasound scanning technique and the scanning protocols for focal mononeuropathies, brachial plexopathies, polyneuropathies, amyotophic lateral sclerosis, and muscle diseases. In this study, a group of neuromuscular ultrasound experts developed six consensus‐based neuromuscular ultrasound scanning protocols that may serve as references for clinicians and researchers. The standardized protocols could also aid in achieving high‐quality uniform neuromuscular ultrasound practices.
Artificial Intelligence for the Detection and Treatment of Atrial Fibrillation
Harmon, David , Sehrawat, Ojasav , Maanja, Maren , Wight, John , Noseworthy, Peter A. , Harmon, David M , Noseworthy, Peter A

Arrhythmia & Electrophysiology Review | April 19, 2023 | Volume: 12 | Issue: No issue available | Pages: No page available

10.15420/aer.2022.31 | PMID 37427304 Get It

AF is the most common clinically relevant cardiac arrhythmia associated with multiple comorbidities, cardiovascular complications (e.g. stroke) and increased mortality. As artificial intelligence (AI) continues to transform the practice of medicine, this review article highlights specific applications of AI for the screening, diagnosis and treatment of AF. Routinely used digital devices and diagnostic technology have been significantly enhanced by these AI algorithms, increasing the potential for large-scale population-based screening and improved diagnostic assessments. These technologies have similarly impacted the treatment pathway of AF, identifying patients who may benefit from specific therapeutic interventions. While the application of AI to the diagnostic and therapeutic pathway of AF has been tremendously successful, the pitfalls and limitations of these algorithms must be thoroughly considered. Overall, the multifaceted applications of AI for AF are a hallmark of this emerging era of medicine.
Navigating Practice Issues Related to the Unsatisfactory Cervicovaginal Papanicolaou Test: Survey Results of Laboratories Participating in the 2020 College of American Pathologists PAP Education Program
Booth, Christine N. , Souers, Rhona J., Tabbara, Sana, Roberson, Janie, Henry, Michael , Sundling, Kaitlin E. , Goodrich, Kelly, Henry, Michael R, Goyal, Abha , Nguyen, Lananh

Archives of Pathology & Laboratory Medicine | April 19, 2023 | Volume: 148 | Issue: 1 | Pages: 48-54

10.5858/arpa.2022-0330-cp | PMID 37074866 Get It

Context.— Unsatisfactory Papanicolaou (Pap) tests pose a unique set of challenges to the laboratory with regard to their processing, review, reporting, and performance of human papillomavirus (HPV) testing. There are no standardized guidelines for the review process and handling of unsatisfactory Pap tests. Objective.— To assess the current practice patterns regarding various aspects of the unsatisfactory Pap test, from processing to reporting, across laboratories worldwide. Design.— A supplemental questionnaire was mailed to laboratories participating in the 2020 College of American Pathologists (CAP) Gynecologic Cytopathology (PAP Education) Program, requesting data regarding the unsatisfactory Pap test. Results.— Of 1520 participating laboratories, 619 (40.7%) responded, and the responses of 577 laboratories were included for further analysis. Only 64.6% (373 of 577) laboratories used the unsatisfactory Pap test criteria as specified by the 2014 Bethesda System. About three-quarters of the respondents (433 of 576; 75.2%) routinely rescreened unsatisfactory Pap tests. Routine repreparation of such Pap tests was performed by 54.9% (316 of 576) of laboratories, and 52.0% (293 of 563) used glacial acetic acid for repreparing excessively bloody specimens. HPV test results were reported for unsatisfactory Pap tests, always or sometimes, by 62.4% (353 of 566) of respondents. Conclusions.— This CAP survey reveals important information regarding the practice patterns pertaining to several aspects of the unsatisfactory Pap test. It also provides valuable insight into the quality assurance measures that can be implemented for such tests. Future studies can further aid in the standardization of all components of the handling of unsatisfactory Pap tests for overall quality improvement.
Novel BCL-2 Inhibitor Lisaftoclax in Relapsed or Refractory Chronic Lymphocytic Leukemia and Other Hematologic Malignancies: First-in-Human Open-Label Trial
Ailawadhi, Sikander , Chen, Zi , Huang, Bo , Paulus, Aneel , Collins, Mary C. , Fu, Lei , Li, Mingyu , Ahmad, Mohammad , Men, Lichuang , Wang, Hengbang , Liang, Eric , Mekala, Divya J. , He, Zhicong , Lasica, Masa , Yannakou, Costas K. , Glass, Laura , Yang, Dajun , Chanan‐Khan, Asher , Fu, Lei Tommy , Davids, Matthew S , Liang, Eric , Mekala, Divya J , He, Zhicong , Lasica, Masa , Yannakou, Costas K , Parrondo, Ricardo D , Glass, Laura , Yang, Dajun , Chanan-Khan, Asher , Zhai, Yifan , Ailawadhi, Sikander , Paulus, Aneel , Davids, Matthew S.

Clinical Cancer Research | April 19, 2023 | Volume: 29 | Issue: 13 | Pages: 2385-2393

10.1158/1078-0432.ccr-22-3321 | PMID 37074726 Get It

Abstract Purpose: This global phase I trial investigated the safety, efficacy, pharmacokinetics, and pharmacodynamics of lisaftoclax (APG-2575), a novel, orally active, potent selective B-cell lymphoma 2 (BCL-2) inhibitor, in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma (R/R CLL/SLL) and other hematologic malignancies (HMs). Patients and Methods: Maximum tolerated dose (MTD) and recommended phase II dose were evaluated. Outcome measures were safety and tolerability (primary) and pharmacokinetic variables and antitumor effects (secondary). Pharmacodynamics in patient tumor cells were explored. Results: Among 52 patients receiving lisaftoclax, MTD was not reached. Treatment-emergent adverse events (TEAEs) included diarrhea (48.1%), fatigue (34.6%), nausea (30.8%), anemia and thrombocytopenia (28.8% each), neutropenia (26.9%), constipation (25.0%), vomiting (23.1%), headache (21.2%), peripheral edema and hypokalemia (17.3% each), and arthralgia (15.4%). Grade ≥ 3 hematologic TEAEs included neutropenia (21.2%), thrombocytopenia (13.5%), and anemia (9.6%), none resulting in treatment discontinuation. Clinical pharmacokinetic and pharmacodynamic results demonstrated that lisaftoclax had a limited plasma residence and systemic exposure and elicited rapid clearance of malignant cells. With a median treatment of 15 (range, 6–43) cycles, 14 of 22 efficacy-evaluable patients with R/R CLL/SLL experienced partial responses, for an objective response rate of 63.6% and median time to response of 2 (range, 2–8) cycles. Conclusions: Lisaftoclax was well tolerated, with no evidence of tumor lysis syndrome. Dose-limiting toxicity was not reached at the highest dose level. Lisaftoclax has a unique pharmacokinetic profile compatible with a potentially more convenient daily (vs. weekly) dose ramp-up schedule and induced rapid clinical responses in patients with CLL/SLL, warranting continued clinical investigation.
Cervical Radiofrequency Ablation Artifact Mimicking an Electrographic Seizure on RNS
Sánchez, Sofía S. , Freund, Brin , Khan, Aafreen , Middlebrooks, Erik H. , Tatum, William O. , Feyissa, Anteneh M. , Middlebrooks, Erik H , Sanchez-Boluarte, Sofia S , Grewal, Sanjeet S.

Journal of Clinical Neurophysiology | April 19, 2023 | Volume: 40 | Issue: 5 | Pages: 478-480

10.1097/wnp.0000000000000989 | PMID 37074333 Get It

Summary: The responsive neurostimulator continuously monitors the electrocorticogram. It delivers short bursts of high-frequency electrical stimulation when personalized patterns are detected. Intracranial EEG recording including electrocorticography is susceptible to artifacts, albeit at a lesser frequency compared with scalp recording. The authors describe a novel case of a patient with focal epilepsy, bitemporal responsive neurostimulation, and seizures without self-awareness manifest as focal impaired awareness seizures adversely affecting memory. At follow-up evaluation, the patient reported being clinically seizure-free although a single long episode was detected using the Patient Data Management System over the course of 3 years. Initial review identified a left-sided rhythmic discharge with a bilateral spatial field of involvement. In response to detection, the responsive neurostimulation delivered a series of five electrical stimulations. On further review, the patient recalled undergoing cervical radiofrequency ablation, which coincided with the appearance of the “electrographic seizure.” Extrinsic electrical artifact involving monomorphic nonevolving waveforms confirmed electrical artifact identified and treated by responsive neurostimulation as an epileptic seizure. On rare occasion, implanted electrical devices may lead to misdiagnosis and mistreatment of patients because of intracranial artifact.